Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) experienced a notable increase during trading on Thursday, surpassing the significant 200-day moving average. The stock, which has a 200-day moving average of $76.89, reached a high of $96.14 before closing at $95.56. The trading volume for the day stood at 94,570 shares, indicating active investor interest.
Wall Street Analysts Weigh In
Recent analyst reports reflect varying perspectives on Mesa Laboratories’ stock. Wells Fargo & Company raised its price target from $83.00 to $94.00 and reiterated an “equal weight” rating in a research note published on February 4, 2024. Meanwhile, on February 7, 2024, Wall Street Zen upgraded the stock from a “buy” to a “strong-buy” rating. In contrast, Weiss Ratings reaffirmed a “sell (d)” rating on January 22, 2024, while Zacks Research elevated its stance from a “strong sell” to a “hold” rating on January 9, 2024. Currently, two analysts have rated the stock as “hold,” and one has issued a “sell” rating. According to MarketBeat.com, the consensus target price sits at $94.00.
Mesa Laboratories Reports Strong Earnings and Dividend Announcement
Mesa Laboratories released its quarterly earnings results on February 3, 2024, reporting earnings per share (EPS) of $3.07, which exceeded analysts’ expectations of $2.41 by $0.66. The company generated revenue of $65.13 million, surpassing the forecast of $63.23 million. Mesa Laboratories reported a net margin of 1.51% and a return on equity of 22.02%. Analysts predict that the company will post an average EPS of $8 for the current year.
In addition to its earnings, Mesa Laboratories announced a quarterly dividend of $0.16 per share, set to be paid on March 16, 2024. Shareholders of record as of February 28, 2024, will receive this dividend, translating to an annualized dividend of $0.64 and a yield of 0.7%. The ex-dividend date is February 27, 2024, with the company’s dividend payout ratio currently at 100.00%.
Institutional investors and hedge funds have played a significant role in Mesa Laboratories’ stock activity. Northwestern Mutual Wealth Management Co. increased its holdings by an impressive 5,366.7% in the fourth quarter, acquiring an additional 322 shares for a total of 328 shares valued at $26,000. Other notable moves include Caitong International Asset Management Co. Ltd, which purchased a new stake valued at $27,000, and Farther Finance Advisors LLC, which boosted its position by 17,733.3%, acquiring 535 shares now worth $36,000. Overall, institutional ownership stands at 90.60% of the company’s stock.
About Mesa Laboratories
Based in Lakewood, Colorado, Mesa Laboratories, Inc. is a global leader in providing instrumentation products for critical process monitoring, testing, and calibration. The company serves various sectors, including healthcare, pharmaceuticals, food and beverage, energy, and industrial markets. Mesa Laboratories emphasizes precision measurement and regulatory compliance, ensuring product safety and operational efficiency in complex manufacturing and sterilization processes. Its product range includes biological and chemical indicators, digital data loggers, environmental sensors, and optical gas analyzers.
Looking ahead, investors will be keen to monitor Mesa Laboratories’ performance as the company continues to navigate the evolving landscape of medical instrumentation and regulatory compliance.
